Literature DB >> 16498281

[Prognostic factors after major resection for distal extrahepatic cholangiocarcinoma].

Jeoung Woo Kim1, Sungho Jo, Hyoun Jong Moon, Jin Seok Heo, Seong Ho Choi, Jae Won Joh, Dong Wook Choi, Jun Chul Chung, Yong Il Kim.   

Abstract

BACKGROUND/AIMS: Although diagnosis and surgical treatment for distal common bile duct cancer have enormously advanced, survival is not satisfactory and its prognostic factors are still being debated. Thus, we evaluated the outcomes and prognostic factors after major resection for distal extrahepatic cholangiocarcinoma (dCC).
METHODS: One hundred and fifty-four patients who underwent major resection such as pancreatic oduodenectomy for dCC were retrospectively analyzed. We investigated clinical features, postoperative complications, survival, and prognostic factors of dCC.
RESULTS: One hundred and three (66.9%) male and 51 (33.1%) female patients were enrolled and their mean age was 59.6 (31-78) years. Among them, 97 patients (63.0%) underwent Whipple's procedure, 45(29.2%) pylorus-preserving pancreatic oduodenectomy, 7 (4.5%) total pancreatectomy, and 5 (3.3%) hepatopancreaticoduodenectomy, respectively. Mean follow-up duration was 26.6 (0.4-108.5) months. The postoperative morbidity and mortality were 42.2% and 1.3%, respectively. Five-year survival rate was 32.8% and mean survival duration was 47.2 (39.1-55.3) months. Type of biliary drainage (percutaneous transhepatic biliary drainage), lymph node status (positive), and cellular differentiation (moderate or poor) were significant indicators for death in multivariate analysis of resectable dCC.
CONCLUSIONS: Moderate or poor cellular differentiation and lymph node metastasis maybe independent poor prognostic factors for resectable dCC.

Entities:  

Mesh:

Year:  2006        PMID: 16498281

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  3 in total

1.  Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor.

Authors:  Haixia Yang; Jiupeng Zhou; Xin Wei; Fan Wang; Huadong Zhao; Enxiao Li
Journal:  Mol Clin Oncol       Date:  2014-08-07

2.  Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery.

Authors:  Hyeon Kang Koh; Hae Jin Park; Kyubo Kim; Eui Kyu Chie; Hye Sook Min; Sung W Ha
Journal:  Radiat Oncol J       Date:  2012-12-31

3.  Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma.

Authors:  Pyung Jung; Eung-Ho Cho; Sang-Bum Kim; Ryoung-Go Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.